Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Withdrawn
NCT06326138
Pharmacokinetics and Pharmacodynamics of Edoxaban Before and After Bariatric Surgery
0
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Bariatric Surgery Candidate
Recruiting
NCT06324396
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
15
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Fontan Circulation
연구종결
KCT0004133
심방세동 환자에서 뇌졸중 예방을 위해 투여되는Edoxaban 또는 warfarin의 장기간 사용이 관상동맥의 동맥 죽상판 진행에 끼치는 영향에 대한 다기관 대조연구
150
Enrollment(s)
1
Study location(s)
관찰연구 (None)
Recruiting
NCT06285942
EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation
168
Enrollment(s)
3
Study location(s)
Interventional (Not Applicable)
Atrial Fibrillation
Fragility
Not yet recruiting
NCT06262685
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
216
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Cardiovascular Diseases
Dyslipidemias
Statin Adverse Reaction
Pharmacogenic Myopathy
Recruiting
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
60
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Acute Myeloid Leukemia in Children
모집 중
KCT0008033
복잡-고위험 관상동맥 중재술을 시행한 급성 관동맥 증후군 환자에서 안정 후 프라수그렐 단독 항혈소판제 요법과 클로피도그렐을 사용한 이중 항혈소판제 요법의 유효성과 안정성을 비교하는 전향적, 다기관 무작위배정 임상연구
2,000
Enrollment(s)
1
Study location(s)
중재연구 (해당사항없음)
Not yet recruiting
NCT06253650
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
46
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Gastric Cancer
HER2-positive Gastric Cancer
16
17
18
19
20